These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7688780)

  • 1. Naloxone modulates NK-cell activity of human peripheral blood lymphocytes like an opioid agonist.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):179-97. PubMed ID: 7688780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between endogenous opioids and IL-2 on PHA-stimulated human lymphocytes.
    Kay NE; Morley JE; Allen JI
    Immunology; 1990 Aug; 70(4):485-91. PubMed ID: 2394465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the opioid antagonist naloxone on human natural killer cell activity in vitro.
    Adelson MO; Novick DM; Khuri E; Albeck H; Hahn EF; Kreek MJ
    Isr J Med Sci; 1994 Sep; 30(9):679-84. PubMed ID: 8088979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endogenous and exogenous opioids on splenic natural killer cell activity.
    Kraut RP; Greenberg AH
    Nat Immun Cell Growth Regul; 1986; 5(1):28-40. PubMed ID: 3010087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
    Mandler RN; Biddison WE; Mandler R; Serrate SA
    J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
    Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
    Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of serotonin in the regulation of human natural killer cell cytotoxicity.
    Hellstrand K; Hermodsson S
    J Immunol; 1987 Aug; 139(3):869-75. PubMed ID: 2439597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
    J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
    Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A
    Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.
    Harris DT; Cianciolo GJ; Snyderman R; Argov S; Koren HS
    J Immunol; 1987 Feb; 138(3):889-94. PubMed ID: 2433333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
    Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K
    Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous opioids and the exercise-induced augmentation of natural killer cell activity.
    Fiatarone MA; Morley JE; Bloom ET; Benton D; Makinodan T; Solomon GF
    J Lab Clin Med; 1988 Nov; 112(5):544-52. PubMed ID: 2972785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha.
    Kutza J; Murasko DM
    Cell Immunol; 1994 Apr; 155(1):195-204. PubMed ID: 7513259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of biological response modifiers on lung natural killer activity.
    Lauzon W; Lemaire I
    Immunopharmacol Immunotoxicol; 1991; 13(3):237-50. PubMed ID: 1719060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.